Applied DNA To Present at 30th Annual Roth Capital Conference on March 13

STONY BROOK, N.Y.–(BUSINESS WIRE)–Applied
DNA Sciences, Inc. (NASDAQ: APDN) today announced that Dr. James
Hayward, president & CEO, is scheduled to present at the 30th
Annual ROTH Capital Markets Conference in Dana Point, CA on Tuesday,
March 13 at 7:30 p.m. ET / 4:30 p.m. PT. Dr. Hayward will also hold
one-on-one meetings with institutional investors and analysts at the
conference.

A live webcast and replay of the presentation will be available on the
company’s investor relations website at http://adnas.com/adnas_home/investors.

About Applied DNA Sciences

Applied DNA is a provider of molecular technologies that enable supply
chain security, anti-counterfeiting and anti-theft technology, product
genotyping and DNA mass production for diagnostics and therapeutics.

We make life real and safe by providing innovative, molecular-based
technology solutions and services that can help protect products,
brands, entire supply chains, and intellectual property of companies,
governments and consumers from theft, counterfeiting, fraud and
diversion. The proprietary DNA-based CertainT®
platform can be used to identify, tag, test, and track products, to help
assure authenticity, origin, traceability, sustainability and quality of
products.

SigNature® DNA describes the core technology ingredient that
is at the heart of a family of uncopyable, security and authentication
solutions such as SigNature®T and fiberTyping®,
targeted towards textiles and apparel, BackTrac® and DNAnet®
andSmartDNA®, for anti-theft and loss
prevention, and digitalDNA®, providing powerful
track-and-trace. All provide a forensic chain of evidence, and can be
used to prosecute perpetrators. Applied DNA Sciences is also engaged in
the large-scale production of specific DNA sequences using the
polymerase chain reaction.

Visit adnas.com for
more information. Follow us on Twitter and LinkedIn.
Join our mailing
list.

Contacts

For Applied DNA Sciences, Inc.
Investors:
Sanjay
M. Hurry, 212-838-3777
LHA Investor Relations
[email protected]
or
Web:
www.adnas.com
| twitter: @APDN